Airway diseases
Respiratory critical care
Oral presentation
COPD: from LABA/ICS to LABA/LAMA/ICS
Methods :
Epidemiology, General respiratory patient care
10:45
Late Breaking Abstract - Blood eosinophil count (EOS) can accurately predict responsiveness to inhaled corticosteroids (ICS) in COPD, but only if measured while patients are not receiving steroids.
A. Mathioudakis(Manchester, United Kingdom)
COI
1
11:00
Late Breaking Abstract - Holter ECG-based arrhythmia and heart rate analysis in patients with COPD receiving a fixed-dose combination of tiotropium/olodaterol versus its monocomponents
S. Andreas(Immenhausen, Germany)
COI
2
11:15
Late Breaking Abstract - Blood eosinophil counts and treatment response in COPD: analyses of IMPACT
S. Pascoe(Bridgewater, United States)
COI
3
11:30
Late Breaking Abstract - IMPACT study — single inhaler triple therapy (FF/UMEC/VI) versus FF/VI and UMEC/VI in patients with COPD: healthcare resource utilization and costs — UK
A. Ismaila(Malvern, United States)
COI
4
11:45
Late Breaking Abstract - Analysis of the InforMing the PAthway of COPD Treatment (IMPACT) study in the subgroup of patients taking triple therapy at screening
D. Singh(Manchester, United Kingdom)
COI
5
12:00
Late Breaking Abstract - Reduction of COPD exacerbations with extrafine single inhaler triple therapy: post-hoc analysis by exacerbation treatment of the TRIBUTE study
L. Fabbri(Modena, Italy)
COI
6
12:15
Late Breaking Abstract - Extrafine single inhaler triple therapy improves quality of life in COPD. Analysis of SGRQ subdomains of the TRIBUTE Study
L. Fabbri(Modena, Italy)
COI
7
12:30
Late Breaking Abstract - Pharmacokinetic and pharmacodynamic interactions between components of extrafine formulation of BDP/FF/GB, a novel fixed-dose triple combination for asthma and COPD
M. Cella(Parma, Italy)
COI
8
. . .
